Drugs / Human Chorionic Gonadotropin (HCG)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02329197 | Oct 2014 → Oct 2015 | infertility disorder | Mansoura University | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 1/2 | NCT04071574 Comparator | Feb 2018 → Aug 2019 | ectopic pregnancy, endometriosis, female infertility, hydrosalpinx +6 | Lebanese University | Completed | No outcome recorded |
| Phase 3 | NCT01599494 Background | Mar 2014 → May 2015 | infertility disorder | Organon and Co | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human Chorionic Gonadotropin (hCG) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01599494 ↗ |
| Route | Subcutaneous | “Single dose of 10,000 or 5,000 IU hCG, administered via SC injection on Day of hCG Administration.” NCT01599494 ↗ |